The Role of Expectancy for Cognitive Enhancement in College Students Using Prescription Stimulants Nonmedically
NCT ID: NCT04635826
Last Updated: 2025-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2025-07-01
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroimaging the Expectancy Versus Pharmacotherapy Effect of Adderall on Cognitive Performance
NCT03530631
Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
NCT02473419
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01238822
Acute Effects of Stimulant Medication in College Students With ADHD
NCT03935646
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adderall/Truth
Participants will be told they are receiving Adderall and will actually be administered Adderall.
Adderall 10Mg Tablet
Participants will be administered Adderall
Adderall/Deception
Participants will be told they are receiving Adderall and will actually be administered placebo
Placebo
Participants will be administered placebo
Placebo/Truth
Participants will be told they are receiving placebo and will actually be administered placebo.
Placebo
Participants will be administered placebo
Placebo/Deception
Participants will be told they are receiving placebo and will actually be administered Adderall
Adderall 10Mg Tablet
Participants will be administered Adderall
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adderall 10Mg Tablet
Participants will be administered Adderall
Placebo
Participants will be administered placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* enrolled as a student at UAB or local college/university
* if female, willing to use adequate birth control or abstain from sexual activity
Exclusion Criteria
* current or prior psychiatric diagnosis (including ADHD)
* neurological disorder or stroke, hypertension, history of blood or circulation disorders (e.g., anemia or sickle-cell), diabetes, brain or spinal abnormalities
* blood pressure more than 130 systolic and 80 diastolic
* heart rate more than 100 beats per minute
* pregnancy
* current illicit substance use as well as nicotine use
* Alcohol or cannabis use that meets DSM-5 criteria for an alcohol or cannabis use disorder
* Inability to abstain from alcohol or cannabis the night before and day of the scanning session
* Inability to reduce caffeine intake to less than 100 mg on testing days in heavy caffeine users
* claustrophobia
* hearing impairment
* vision impairment that cannot be corrected by MRI-compatible lenses
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Cropsey
Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen Cropsey, PsyD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
David Knight, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
300006362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.